These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26002138)

  • 41. Hypermucoviscosity associated with Klebsiella pneumoniae-mediated invasive syndrome: a prospective cross-sectional study in Taiwan.
    Lee CH; Liu JW; Su LH; Chien CC; Li CC; Yang KD
    Int J Infect Dis; 2010 Aug; 14(8):e688-92. PubMed ID: 20547084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia.
    Ku NS; Kim YC; Kim MH; Song JE; Oh DH; Ahn JY; Kim SB; Kim HW; Jeong SJ; Han SH; Kim CO; Song YG; Kim JM; Choi JY
    Arch Gerontol Geriatr; 2014; 58(1):105-9. PubMed ID: 23988261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypervirulent Klebsiella pneumoniae, a 5-year study in a French ICU.
    Rafat C; Messika J; Barnaud G; Dufour N; Magdoud F; Billard-Pomarès T; Gaudry S; Dreyfuss D; Branger C; Decré D; Ricard JD
    J Med Microbiol; 2018 Aug; 67(8):1083-1089. PubMed ID: 29972348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Klebsiella pneumoniae bacteraemia in a region of Canada.
    Pépin J; Yared N; Alarie I; Lanthier L; Vanasse A; Tessier P; Deveau J; Chagnon MN; Comeau R; Cotton P; Libby SJ; Valiquette L
    Clin Microbiol Infect; 2010 Feb; 16(2):141-6. PubMed ID: 19673962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China.
    Li W; Sun G; Yu Y; Li N; Chen M; Jin R; Jiao Y; Wu H
    Clin Infect Dis; 2014 Jan; 58(2):225-32. PubMed ID: 24099919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver abscess caused by magA+ Klebsiella pneumoniae in North America.
    Fang FC; Sandler N; Libby SJ
    J Clin Microbiol; 2005 Feb; 43(2):991-2. PubMed ID: 15695726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae from bloodstream infections and risk factors for mortality.
    Gürntke S; Kohler C; Steinmetz I; Pfeifer Y; Eller C; Gastmeier P; Schwab F; Leistner R
    J Infect Chemother; 2014 Dec; 20(12):817-9. PubMed ID: 25224765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes.
    Yu WL; Ko WC; Cheng KC; Lee CC; Lai CC; Chuang YC
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):1-6. PubMed ID: 18486404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
    Paterson DL; Mulazimoglu L; Casellas JM; Ko WC; Goossens H; Von Gottberg A; Mohapatra S; Trenholme GM; Klugman KP; McCormack JG; Yu VL
    Clin Infect Dis; 2000 Mar; 30(3):473-8. PubMed ID: 10722430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Wang SS; Lee NY; Hsueh PR; Huang WH; Tsui KC; Lee HC; Wu CJ; Chang CM; Huang CC; Huang CF; Ko WC
    J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care.
    Tseng CP; Wu HS; Wu TH; Lin YT; Fung CP
    J Microbiol Immunol Infect; 2013 Jun; 46(3):217-23. PubMed ID: 22832028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Kang CI; Kim SH; Kim DM; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Infect Control Hosp Epidemiol; 2004 Oct; 25(10):860-7. PubMed ID: 15518030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: comparative virulence analysis with hypermucoviscosity-negative strain.
    Lin YC; Lu MC; Tang HL; Liu HC; Chen CH; Liu KS; Lin C; Chiou CS; Chiang MK; Chen CM; Lai YC
    BMC Microbiol; 2011 Mar; 11():50. PubMed ID: 21385400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008.
    Lin YT; Jeng YY; Chen TL; Fung CP
    BMC Infect Dis; 2010 Oct; 10():307. PubMed ID: 20973971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Community-onset Escherichia coli and Klebsiella pneumoniae bacteremia: influence of health care exposure on antimicrobial susceptibility.
    Sun HY; Chen SY; Chang SC; Pan SC; Su CP; Chen YC
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):135-41. PubMed ID: 16529901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reinfection and relapse of recurrent bacteremia caused by Klebsiella pneumoniae in a medical center in Taiwan.
    Huang YT; Liao CH; Teng LJ; Hsu HS; Hsueh PR
    Future Microbiol; 2016 Sep; 11():1157-65. PubMed ID: 27546104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
    Nadkarni AS; Schliep T; Khan L; Zeana CB
    Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.